The Independent reports on @Annals_Oncology @myESMO research paper on 'fat jabs' reducing risk of #obesity related cancers (full paper here: www.annalsofoncology.org/article/S092...: www.independent.co.uk/news/health/...
Recent data show that glucagon-like peptide-1 receptor agonist (GLP-1RA) use is associated
with decreased cancer incidence in diabetic and obese patients. However, there have
been no studies exclusive...
